Hepatitis  >>  tenofovir disoproxil fumarate  >>  Phase 2
Welcome,         Profile    Billing    Logout  

4 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
tenofovir disoproxil fumarate / Generic mfg.
NCT01334567: Rollover Protocol Continued Access to Tenofovir Disoproxil Fumarate (TDF) for Subjects in Taiwan

Completed
2
30
RoW
Tenofovir DF, Viread®
Gilead Sciences
Hepatitis B
12/13
12/13
NCT02452528: Study of ARC-520 in Participants With Hepatitis B Virus e Antigen (HBeAg) Positive Chronic Hepatitis B Virus

Terminated
2
4
US
ARC-520, Placebo, Entecavir, Baraclude, Tenofovir, Viread, diphenhydramine
Arrowhead Pharmaceuticals
Chronic Hepatitis B
12/16
12/16
Monarch, NCT02577029 / 2015-005499-46: Study of ARC-520 With or Without Other Drugs Used in the Treatment of Chronic Chronic Hepatitis B Virus (HBV)

Terminated
2
79
Europe, RoW
ARC-520, entecavir, Baraclude, pegylated interferon alpha 2a, Peginterferon, Pegasys, tenofovir disoproxil, Viread, antihistamine
Arrowhead Pharmaceuticals
Hepatitis B, Hepatitis D
12/16
12/16
HIDIT-II, NCT00932971 / 2008-005560-13: HIDIT II - PegIFN-alfa2a Plus Tenofovir in Chronic Delta Hepatitis

Completed
2
70
Europe
PEG-IFN alfa-2a, Tenofovir, Pegasys, Viread, PEG-IFN alfa-2a, placebo
HepNet Study House, German Liverfoundation, Hannover Medical School, Hoffmann-La Roche, Gilead Sciences
Hepatitis D
08/17
08/17

Download Options